Dr. Newman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
177 Fort Washington Ave.
6th Floor, Ctr 12
New York, NY 10032Phone+1 212-305-2913
Education & Training
- New York Presbyterian Hospital(Cornell Campus)/Coney Island HospitalFellowship, Cardiovascular Disease, 2009 - 2013
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2005 - 2008
- Northwestern University The Feinberg School of MedicineClass of 2005
Certifications & Licensure
- NY State Medical License 2007 - 2026
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Vegan vs AHA Diet on Inflammation and Glucometabolic Profile in Patients With CAD Start of enrollment: 2014 Mar 11
Publications & Presentations
PubMed
- 1 citationsEvolocumab in Older Individuals: Expanding the Age Horizon.Kalyani Dhar, Jeffrey Berger, Jonathan Newman, Arthur Schwartzbard, Astrid Carolina Jara Pernia
Journal of the American College of Cardiology. 2025-02-11 - Dynamic perioperative platelet activity and cardiovascular events in peripheral artery disease.Natalie N Kennedy, Yuhe Xia, Tessa Barrett, Elliot Luttrell-Williams, Todd Berland
Journal of Vascular Surgery. 2025-02-01 - Variation in lipoprotein(a) response to potent lipid lowering: The role of apolipoprotein (a) isoform size.Adedoyin Akinlonu, Michael B Boffa, Chen Lyu, Judy Zhong, Manila Jindal
Journal of Clinical Lipidology. 2024-12-04
Journal Articles
- Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of DiabetesVivian Fonseca, David M Nathan, Jonathan Newman, The Journal of Clinical Endocrinology and Metabolism
- The Changing Landscape of Diabetes Therapy for Cardiovascular Risk ReductionArthur Z Schwartzbard, Jonathan D Newman, Howard S Weintraub, Jeffrey S Berger, Anish K Vani, ScienceDirect
Press Mentions
- NYU Langone Heart’s Leading Cardiologists Present Latest Research at the American Heart Association’s Scientific Sessions 2024November 17th, 2024
- News Coverage of NYU Langone Health for Tuesday, May 9, 2023May 10th, 2023
- Diabetes Drugs May Help Reduce Risk of Cardiovascular Events in Older AdultsMay 8th, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: